"We aim to be an attractive and preferred partner to exciting life science companies"
How we seek to create value
We combine deep industry experience with an entrepreneurial mindset. The RHP team has operated and invested across the life-science value chain — from early research and clinical development to manufacturing and commercialisation. This hands-on background enables us to act as an active owner and true partner, supporting portfolio companies with strategic insight, network access, and operational guidance.
​
-
Sector-specific experience across biologics, biotech tools, and healthcare services
-
Active ownership and board-level engagement
-
Strong Nordic and international investor network
-
Proven ability to scale high-growth life-science businesses
​
We seek to make investments in high-growth, post-proof-of-concept companies looking to unlock their next phase of growth
​We’re investing in the solutions
Building profitable companies that enable the healthcare of tomorrow
As an alternative investment fund manager registered with the Norwegian Financial Supervisory Authority, Rubicon Healthcare Partners AS is subject to Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector (SFDR). No funds under management promote environmental or social characteristics or have sustainable investments as its investment objective. Thus, all funds under management are classified as article 6 funds in accordance with SFDR. Our entity level disclosures pursuant to SFDR article 3, 4 and 5 can be found here.